PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27865621-5	2016	Menaquinone-4 (MK-4) with 4 isoprene units, vitamin K2, has been shown to induce bone-type ALP activity and osteoblastogenesis in human bone marrow cells.	Vitamin K 2	44-54	alkaline phosphatase, placental	Homo sapiens	91-94	
27865621-10	2016	This is the first report concerning ALP messenger RNA expression induced by vitamin K2 in Caco-2 cells.	Vitamin K 2	76-86	alkaline phosphatase, placental	Homo sapiens	36-39	
15003806-11	2004	Although there was no significant change of the alkaline phosphatase (ALP) level during the 12 months before the start of vitamin K2 therapy, there was a significant increase of alkaline phosphatase after vitamin K2 administration.	Vitamin K 2	205-215	alkaline phosphatase, placental	Homo sapiens	178-198	
8939773-3	1996	Vitamin K2 (2-methyl-3-all-trans-tetraphenyl-1, 4-naphthoquinone : menatetrenone) was the most potent of these vitamin K analogs; it slightly inhibited alkaline phosphatase (ALP) activity.	Vitamin K 2	0-10	alkaline phosphatase, placental	Homo sapiens	152-172	
8939773-3	1996	Vitamin K2 (2-methyl-3-all-trans-tetraphenyl-1, 4-naphthoquinone : menatetrenone) was the most potent of these vitamin K analogs; it slightly inhibited alkaline phosphatase (ALP) activity.	Vitamin K 2	0-10	alkaline phosphatase, placental	Homo sapiens	174-177	
8939773-5	1996	Vitamin K2 promoted the 1,25(OH)2D3-induced mineralization, but slightly inhibited the 1,25(OH)2D3-induced ALP activity.	Vitamin K 2	0-10	alkaline phosphatase, placental	Homo sapiens	107-110